Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis
Authors
Keywords
-
Journal
HEART
Volume 101, Issue 15, Pages 1204-1211
Publisher
BMJ
Online
2015-06-04
DOI
10.1136/heartjnl-2015-307489
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Intracerebral Hemorrhage Associated with New Oral Anticoagulant Use
- (2014) Roland Veltkamp et al. CLINICS IN LABORATORY MEDICINE
- ‘New’ direct oral anticoagulants in the perioperative setting
- (2014) Georg Breuer et al. Current Opinion in Anesthesiology
- Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
- (2014) Daniel Caldeira et al. HEART
- Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis
- (2014) Daniel Caldeira et al. JOURNAL OF NEUROLOGY
- Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis
- (2014) Antonio Gómez-Outes et al. THROMBOSIS RESEARCH
- Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism
- (2013) Soheir S. Adam et al. ANNALS OF INTERNAL MEDICINE
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Reversal of novel oral anticoagulants in patients with major bleeding
- (2013) Deborah M. Siegal et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews
- (2013) Rebecca M. Turner et al. PLoS One
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis of incidence of rare events
- (2012) Peter W Lane STATISTICAL METHODS IN MEDICAL RESEARCH
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses
- (2008) Jesper Brok et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More